Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at durvalumab and tremelimumab for non small cell lung cancer (POSEIDON)

Overview

Cancer types:

Lung cancer, Non small cell lung cancer (NSCLC)

Status:

Closed

Phase:

Phase 3

Details

This trial is for people with non small cell lung cancer that has spread from where it started in the lung (advanced). It is for people who are going to have treatment for the first time.

Recruitment start: 25 September 2017

Recruitment end: 7 August 2018

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Siow-Ming Lee

Supported by

AstraZeneca

Last reviewed: 03 Oct 2018

CRUK internal database number: 15097

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.